BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND GMPS, ENSG00000163655, 8833
11 results:

  • 1. Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.
    van Veghel W; van Dijk SC; Klem TM; Weel AE; Bügel JB; Birnie E
    BMJ Open; 2024 May; 14(5):e080257. PubMed ID: 38692726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.
    Hao X; Shen Y; Chen N; Zhang W; Valverde E; Wu L; Chan HL; Xu Z; Yu L; Gao Y; Bado I; Michie LN; Rivas CH; Dominguez LB; Aguirre S; Pingel BC; Wu YH; Liu F; Ding Y; Edwards DG; Liu J; Alexander A; Ueno NT; Hsueh PR; Tu CY; Liu LC; Chen SH; Hung MC; Lim B; Zhang XH
    Cell Stem Cell; 2023 May; 30(5):648-664.e8. PubMed ID: 37146584
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.
    Zhang R; Dong M; Tu J; Li F; Deng Q; Xu J; He X; Ding J; Xia J; Sheng D; Chang Z; Ma W; Dong H; Zhang Y; Zhang L; Zhang L; Liu S
    Signal Transduct Target Ther; 2023 Mar; 8(1):97. PubMed ID: 36859354
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells.
    Magidey-Klein K; Cooper TJ; Kveler K; Normand R; Zhang T; Timaner M; Raviv Z; James BP; Gazit R; Ronai ZA; Shen-Orr S; Shaked Y
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34140316
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC breast cancer Cell Line.
    Kollareddy M; Martinez LA
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918387
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-gmps interaction promotes the growth of p53 wild-type breast cancers by degrading p53.
    Su X; Feng C; Wang S; Shi L; Gu Q; Zhang H; Lan X; Zhao Y; Qiang W; Ji M; Hou P
    Cell Death Differ; 2021 Aug; 28(8):2450-2464. PubMed ID: 33742136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Grand multiparity and reproductive cancer in the Jerusalem Perinatal Study Cohort.
    Paltiel O; Tajuddin SM; Polanker Y; Yazdgerdi S; Manor O; Friedlander Y; Harlap S; Calderon-Margalit R
    Cancer Causes Control; 2016 Feb; 27(2):237-47. PubMed ID: 26669321
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization.
    Reddy BA; van der Knaap JA; Bot AG; Mohd-Sarip A; Dekkers DH; Timmermans MA; Martens JW; Demmers JA; Verrijzer CP
    Mol Cell; 2014 Feb; 53(3):458-70. PubMed ID: 24462112
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC study.
    Descotes F; Jézéquel P; Spyratos F; Campion L; Grenot C; Lerebours F; Campone M; Guérin-Charbonnel C; Lanoë D; Adams M; André J; Carlioz A; Martin PM; Chassevent A; Jourdan ML; Guette C; Zanella-Cleon I; Ricolleau G
    Int J Oncol; 2012 Jul; 41(1):92-104. PubMed ID: 22552268
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
    Straume O; Akslen LA
    Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.
    Straume O; Chappuis PO; Salvesen HB; Halvorsen OJ; Haukaas SA; Goffin JR; Bégin LR; Foulkes WD; Akslen LA
    Cancer Res; 2002 Dec; 62(23):6808-11. PubMed ID: 12460889
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.